NCT02781584: A trial that was reported late by Gilead Sciences
This trial has reported, although it was 18 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02781584 |
|---|---|
| Title | A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 13, 2016 |
| Completion date | Dec. 17, 2020 |
| Required reporting date | Dec. 17, 2021, midnight |
| Actual reporting date | Jan. 4, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 18 |